Long-term trial shows implantable defibrillators may benefit younger patients with mild-to-moderate heart dysfunction
Source Summary
A decade-long clinical trial led by Flinders University Professor Joseph Selvanayagam has demonstrated that implantable cardioverter-defibrillators may provide life-saving treatment for younger patients with mild-to-moderate heart dysfunction. The findings were presented at the European Society of Cardiology Congress in Munich and published in JAMA.
Why it matters
The trial results expand potential treatment options for a younger patient population previously considered ineligible for implantable defibrillators, potentially preventing sudden cardiac death in this group.
